BMC Pulmonary Medicine
Scope & Guideline
Transforming the landscape of respiratory health through scholarship.
Introduction
Aims and Scopes
- Pulmonary Disease Research:
The journal covers a wide range of pulmonary diseases, including chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, lung cancer, and pulmonary hypertension, emphasizing both clinical and translational research. - Innovative Diagnostic Techniques:
Research focusing on novel diagnostic approaches such as imaging techniques (e.g., CT and MRI), biomarkers, and endobronchial ultrasound is prevalent, promoting advancements in early detection and monitoring of lung diseases. - Therapeutic Interventions:
The journal publishes studies on various treatment modalities including pharmacological interventions, surgical approaches, and emerging therapies such as biologics and immunotherapy, aiming to improve patient outcomes. - Public Health and Epidemiology:
There is a strong emphasis on epidemiological studies that investigate the prevalence, risk factors, and socio-economic impacts of respiratory diseases, particularly in diverse populations. - Patient-Centered Outcomes:
Research evaluating health-related quality of life, patient experiences, and adherence to treatment regimens is prioritized, reflecting a commitment to improving patient care in pulmonary medicine. - Mechanistic and Pathophysiological Studies:
The journal includes studies that explore the underlying mechanisms of pulmonary diseases, including genetic, molecular, and cellular factors contributing to disease progression.
Trending and Emerging
- Telemedicine and Remote Monitoring:
The COVID-19 pandemic has accelerated the adoption of telehealth strategies in pulmonary care, with increasing research on the effectiveness of remote monitoring and virtual rehabilitation programs for managing chronic respiratory diseases. - Personalized Medicine and Biomarkers:
There is a growing focus on personalized approaches in treatment, including the use of biomarkers for tailoring therapies in conditions like asthma and idiopathic pulmonary fibrosis, reflecting advancements in precision medicine. - Impact of Environmental Factors:
Research increasingly addresses the effects of air pollution, occupational exposures, and climate change on respiratory health, emphasizing the need for public health interventions and policy changes. - Machine Learning and Artificial Intelligence:
The integration of machine learning and AI in diagnostic and prognostic models for lung diseases is emerging as a key area of research, enhancing predictive accuracy and patient outcomes. - Multimorbidity in Pulmonary Diseases:
An increasing number of studies are addressing the intersection of pulmonary diseases with other chronic conditions, focusing on comprehensive management strategies that consider the whole patient. - Health Disparities and Access to Care:
Research investigating health disparities in respiratory diseases, particularly among underserved populations, is gaining attention, highlighting the need for equitable healthcare access.
Declining or Waning
- Traditional Smoking Cessation Studies:
Research solely focused on methods for smoking cessation has declined, as the journal shifts toward integrated approaches that consider smoking as part of a broader spectrum of pulmonary disease management. - Single-Disease Focus:
There is a noticeable reduction in studies exclusively targeting individual diseases without considering comorbidities, as the journal increasingly emphasizes the interconnectedness of various respiratory conditions. - Basic Science without Clinical Relevance:
The journal appears to be moving away from purely basic science studies that do not have direct clinical implications, prioritizing translational research that impacts patient care. - Outdated Therapeutic Approaches:
Research centered on older therapeutic modalities without new insights or comparative effectiveness has diminished, reflecting a trend towards innovative and evidence-based treatment strategies.
Similar Journals
RESPIRATORY RESEARCH
Advancing the Frontiers of Pulmonary ScienceRESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.
RESPIRATION
Fostering Collaboration for Respiratory BreakthroughsRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
Pulmonary Circulation
Elevating the discourse in pulmonary and respiratory medicine.Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.
THORAX
Championing excellence in respiratory research.THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.
Journal of Thoracic Disease
Transforming thoracic care with cutting-edge insights.Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.
Lung India
Connecting researchers and clinicians for impactful findings.Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.
RESPIROLOGY
Setting the Standard in Respiratory ResearchRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
Chronic Respiratory Disease
Transforming insights into improved patient care.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
LUNG
Innovating the future of pulmonary medicine with every publication.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
Turkish Thoracic Journal
Elevating respiratory medicine with open-access discoveries.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.